{
     "PMID": "27801959",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20171222",
     "LR": "20171222",
     "IS": "1460-9568 (Electronic) 0953-816X (Linking)",
     "VI": "45",
     "IP": "4",
     "DP": "2017 Feb",
     "TI": "Different synaptic stimulation patterns influence the local androgenic and estrogenic neurosteroid availability triggering hippocampal synaptic plasticity in the male rat.",
     "PG": "499-509",
     "LID": "10.1111/ejn.13455 [doi]",
     "AB": "Electrophysiological recordings were used to investigate the role of the local synthesis of 17beta-estradiol (E2) and 5alpha-dihydrotestosterone (DHT) on synaptic long-term effects induced in the hippocampal CA1 region of male rat slices. Long-term depression (LTD) and long-term potentiation (LTP), induced by different stimulation patterns, were examined under the block of the DHT synthesis by finasteride (FIN), and the E2 synthesis by letrozole (LET). We used low frequency stimulation (LFS) for LTD, high frequency stimulation (HFS) for LTP, and intermediate patterns differing in duration or frequency. We found that FIN reverted the LFS-LTD into LTP and enhanced LTP induced by intermediate and HFSs. These effects were abolished by exogenous DHT at concentration higher than the basal one, suggesting a stimulus dependent increase in DHT availability. No effect on the synaptic responses was observed giving DHT alone. Moreover, we found that the inhibition of E2 synthesis influenced the HFS-LTP by reducing its amplitude, and the exogenous E2 either enhanced HFS-LTP or reverted the LFS-LTD into LTP. The equivalence of the E2 concentration for rescuing the full HFS-LTP under LET and reverting the LFS-LTD into LTP suggests an enhancement of the endogenous E2 availability that is specifically driven by the HFS. No effect of FIN or LET was observed on the responses to stimuli that did not induce either LTD or LTP. This study provides evidence that the E2 and DHT availability combined with specific stimulation patterns is determinant for the sign and amplitude of the long-term effects.",
     "CI": [
          "(c) 2016 Federation of European Neuroscience Societies and John Wiley & Sons Ltd."
     ],
     "FAU": [
          "Di Mauro, Michela",
          "Tozzi, Alessandro",
          "Calabresi, Paolo",
          "Pettorossi, Vito Enrico",
          "Grassi, Silvarosa"
     ],
     "AU": [
          "Di Mauro M",
          "Tozzi A",
          "Calabresi P",
          "Pettorossi VE",
          "Grassi S"
     ],
     "AD": "Dipartimento di Medicina Sperimentale, Sezione di Fisiologia e Biochimica, Universita di Perugia, Via Gambuli, 06156, Perugia, Italy. Dipartimento di Medicina Sperimentale, Sezione di Fisiologia e Biochimica, Universita di Perugia, Via Gambuli, 06156, Perugia, Italy. Fondazione Santa Lucia - I.R.C.C.S., Rome, Italy. Fondazione Santa Lucia - I.R.C.C.S., Rome, Italy. Dipartimento di Medicina, Clinica Neurologica, Universita di Perugia, Perugia, Italy. Dipartimento di Medicina Sperimentale, Sezione di Fisiologia e Biochimica, Universita di Perugia, Via Gambuli, 06156, Perugia, Italy. Dipartimento di Medicina Sperimentale, Sezione di Fisiologia e Biochimica, Universita di Perugia, Via Gambuli, 06156, Perugia, Italy.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170202",
     "PL": "France",
     "TA": "Eur J Neurosci",
     "JT": "The European journal of neuroscience",
     "JID": "8918110",
     "RN": [
          "0 (5-alpha Reductase Inhibitors)",
          "0 (Aromatase Inhibitors)",
          "0 (Nitriles)",
          "0 (Triazoles)",
          "3XMK78S47O (Testosterone)",
          "4TI98Z838E (Estradiol)",
          "57GNO57U7G (Finasteride)",
          "5H7I2IP58X (boldenone)",
          "7LKK855W8I (letrozole)"
     ],
     "SB": "IM",
     "MH": [
          "5-alpha Reductase Inhibitors/pharmacology",
          "Animals",
          "Aromatase Inhibitors/pharmacology",
          "Estradiol/*metabolism/pharmacology",
          "Finasteride/pharmacology",
          "Hippocampus/*drug effects/physiology",
          "*Long-Term Potentiation",
          "*Long-Term Synaptic Depression",
          "Male",
          "Nitriles/pharmacology",
          "Rats",
          "Rats, Wistar",
          "Synaptic Potentials",
          "Testosterone/*analogs & derivatives/metabolism/pharmacology",
          "Triazoles/pharmacology"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "17beta-estradiol",
          "5alpha-dihydrotestosterone",
          "hippocampus",
          "long-term depression",
          "long-term potentiation"
     ],
     "EDAT": "2016/11/02 06:00",
     "MHDA": "2017/12/23 06:00",
     "CRDT": [
          "2016/11/02 06:00"
     ],
     "PHST": [
          "2016/07/07 00:00 [received]",
          "2016/10/21 00:00 [revised]",
          "2016/10/27 00:00 [accepted]",
          "2016/11/02 06:00 [pubmed]",
          "2017/12/23 06:00 [medline]",
          "2016/11/02 06:00 [entrez]"
     ],
     "AID": [
          "10.1111/ejn.13455 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Neurosci. 2017 Feb;45(4):499-509. doi: 10.1111/ejn.13455. Epub 2017 Feb 2.",
     "term": "hippocampus"
}